Sms Pharmaceuticals Ltd vs Venus Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of SMS Pharmaceuticals Ltd is ₹ 384.45 as of 12 Jun 15:30 . The P/E Ratio of SMS Pharmaceuticals Ltd changed from 16.8 on March 2021 to 27.3 on March 2025 . This represents a CAGR of 10.20% over 5 yearsThe P/E Ratio of Venus Remedies Ltd changed from 5.5 on March 2021 to 8.8 on March 2025 . This represents a CAGR of 9.86% over 5 years The Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 1053 crore on March 2021 to ₹ 1885 crore on March 2025 . This represents a CAGR of 12.36% over 5 yearsThe Market Cap of Venus Remedies Ltd changed from ₹ 338.91 crore on March 2021 to ₹ 400.47 crore on March 2025 . This represents a CAGR of 3.39% over 5 years The revenue of SMS Pharmaceuticals Ltd for the Mar '26 is ₹ 240.52 crore as compare to the Dec '25 revenue of ₹ 214.2 crore. This represent the growth of 12.29% The revenue of Venus Remedies Ltd for the Mar '26 is ₹ 264.35 crore as compare to the Dec '25 revenue of ₹ 182.78 crore. This represent the growth of 44.63% The ebitda of SMS Pharmaceuticals Ltd for the Mar '26 is ₹ 42.47 crore as compare to the Dec '25 ebitda of ₹ 47.4 crore. This represent the decline of -10.4% The ebitda of Venus Remedies Ltd for the Mar '26 is ₹ 68.37 crore as compare to the Dec '25 ebitda of ₹ 40.04 crore. This represent the growth of 70.75% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 16.37 crore to ₹ 20.96 crore over 8 quarters. This represents a CAGR of 13.15% The net profit of Venus Remedies Ltd changed from ₹ 1.22 crore to ₹ 47.5 crore over 8 quarters. This represents a CAGR of 523.97% The Dividend Payout of SMS Pharmaceuticals Ltd changed from 4.17 % on March 2021 to 5.19 % on March 2025 . This represents a CAGR of 4.47% over 5 yearsThe Dividend Payout of Venus Remedies Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited was incorporated in December, 1987.
The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s.
VKT Pharma Private Limited.

About Venus Remedies Ltd

Incorporated in 1989 Venus Remedies Limited, formerly known as Venus Glucose Pvt Ltd, was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited.
The Company was promoted and managed by Chaudhary & Family.
The Company is one of the handful player in pharmaceutical sector to launch injectables globally.
It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India). At present, Venus focuses on specialized therapeutic areas including anti-infectives (antibiotics), oncology, neurology, pain management, and skin and wound care.
In priority, the Company was mainly engaged in I/V Fluids & Injectables, Ceftazidime, Amlodipine, Gliclazide, Lisinopril, etc. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana.

FAQs for the comparison of SMS Pharmaceuticals Ltd and Venus Remedies Ltd

Which company has a larger market capitalization, SMS Pharmaceuticals Ltd or Venus Remedies Ltd?

Market cap of SMS Pharmaceuticals Ltd is 3,600 Cr while Market cap of Venus Remedies Ltd is 2,407 Cr

What are the key factors driving the stock performance of SMS Pharmaceuticals Ltd and Venus Remedies Ltd?

The stock performance of SMS Pharmaceuticals Ltd and Venus Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for SMS Pharmaceuticals Ltd and Venus Remedies Ltd?

As of June 15, 2026, the SMS Pharmaceuticals Ltd stock price is INR ₹384.45. On the other hand, Venus Remedies Ltd stock price is INR ₹1801.25.

How do dividend payouts of SMS Pharmaceuticals Ltd and Venus Remedies Ltd compare?

To compare the dividend payouts of SMS Pharmaceuticals Ltd and Venus Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.